ClearPoint Neuro, Inc.
USD18.08
-1.35 (-6.95%)
CEO
Joseph Michael Burnett
IPO Date
2012-05-22
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$19.19
Prev. Close
$19.43
Day Low
$17.69
Day High
$19.28
52W Low
$8.27
52W High
$30.10
Market Cap
$0.54B
Volume
0.39M
| -22.0 |
| 31 Dec 2023 | FY | 56.8% | -92.2% | -104.3% | -51.8% | 0.66 | 4.87 | -7.6 |
| 31 Dec 2022 | FY | 65.8% | -80.0% | -44.6% | -29.6% | 0.32 | 7.54 | -12.5 |
| 31 Dec 2021 | FY | 68.2% | -88.4% | -29.5% | -22.0% | 0.25 | 13.02 | -16.1 |
| 31 Dec 2020 | FY | 71.1% | -52.9% | -285.3% | -23.0% | 10.15 | 7.96 | -37.1 |
| 31 Dec 2019 | FY | 64.9% | -49.4% | -120.8% | -46.4% | 0.54 | 2.71 | -11.4 |
| 31 Dec 2018 | FY | 66.9% | -83.8% | -407.9% | -78.4% | 2.30 | 3.31 | -2.8 |
| 31 Dec 2017 | FY | 60.7% | -97.1% | -123.0% | -51.6% | 0.84 | 2.90 | -3.0 |
| 31 Dec 2016 | FY | 54.0% | -140.4% | 1067.3% | -109.0% | -5.94 | 2.02 | -1.2 |
| -12.4 |
| 30 Sept 2025 | Q3 | 63.2% | -66.5% | -37.1% | -9.8% | 2.25 | 6.37 | -26.3 |
| 30 Jun 2025 | Q2 | 60.3% | -63.3% | -29.6% | -9.3% | 1.80 | 7.30 | -14.5 |
| 31 Mar 2025 | Q1 | 60.5% | -71.0% | -30.1% | -20.0% | 0.17 | 3.53 | -13.7 |
| 31 Dec 2024 | Q4 | 61.3% | -69.3% | -21.2% | -13.7% | 0.14 | 3.22 | -19.3 |
| 30 Sept 2024 | Q3 | 59.7% | -61.2% | -17.2% | -12.4% | 0.13 | 4.54 | -15.5 |
| 30 Jun 2024 | Q2 | 63.5% | -56.1% | -13.7% | -8.4% | 0.43 | 2.79 | -8.3 |
| 31 Mar 2024 | Q1 | 59.2% | -54.3% | -12.0% | -7.7% | 0.40 | 3.13 | -10.3 |
| 31 Dec 2023 | Q4 | 58.9% | -67.8% | -21.8% | -10.8% | 0.66 | 4.87 | -9.1 |